TheJobsMapAbout X37
X-37 has closed a $14.5 million Series A financing, led by DCVC Bio and joined by Alpha Intelligence Capital and Hemi Ventures. X-37 was cofounded by AtomWise and an experienced team of pharmaceutical developers from Velocity Pharmaceutical Development. With AtomWise’s top #AI platform, we have already generated promising hits against ZAP-70 for autoimmune diseases, PIM3 and SHP2 for #cancer, and Factor XIIa #anticoagulation.
Founded in 2018 by Abraham Heifets and Matt Kerby.
- Founded
- 2018
- Employees
- 1 to 10
- Total funding
- $14.5M
- Headquarters
- South San Francisco
Leadership
The top of X37's org chart, with how many people report into each leader.
David Collier
CEO & Board Member
4 reports
James Larrick
Head of Target Identification
Ed Schnipper
Head of Clinical Development
Anie Roche
General Counsel
Andrew Pearlman
Head of Non-Clinical Development
Board
David Gluckman
Board Member
Antoine Blondeau
Board Member
Abraham Heifets
Board Member
Kiersten Stead
Board Member
Jobs at X37
No open positions right now. Explore more companies on TheJobsMap.